SENSEX    73651.35       655.04    |    NIFTY    22326.9       203.25 FAQ    |    Feedback
EQUITIES
DERIVATIVES
IPO
Gainers & Losers Value & Volume Toppers 52 Weeks High/Low Advances & Declines
New High-Low
Pre-Session Mid-Session End-Session Other Markets Market Beat Stock Alert
Hot Pursuit Foreign Markets Economy News Corporate News Corporate Results
Detailed Quotes Board of Directors Balance Sheet Profit & Loss Quarterly Results Historical Price
Financial Ratios Company Background Technical Chart
Announcements Book Closure Board Meetings Bonus Issues Rights Issues
De-Listed Shares Name Change Split of Face Value Market Turnover
FII Investments MF Investments ADR Prices World Indices
Forthcoming IPOs
Open IPOs
Closed IPOs
New Listing
Basis Of Allotment Draft Prospectus New Issue Monitor
Get Quotes
Gainers
Losers
Value Toppers Advances & Declines Ticker Spot
Ticker Futures Closing Price Technical Chart Commodity News MCX Currency Futures
Get Quotes NIFTY Futures Top Traded Value Top Quantity Most Active Contracts
FII Statistics Daily Settlement Price List of Underlyings Put Call Ratio Derivative Summary
All Index Futures Top Gainers Top Losers Most Active Put Most Active Call
Highest in OI Lowest in OI Increase in OI Decrease in OI
Stock Alert
Overall view of all the recent market developments which will help in your investment decisions
Sun Pharma in focus after FDA nod for psoriasis drug
22-Mar-18   07:58 Hrs IST

Sun Pharmaceutical Industries (Sun Pharma) announced that the United States Food and Drug Administration (FDA) has approved ILUMYA (tildrakizumab-asmn) for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. The announcement was made after market hours yesterday, 21 March 2018.

Majesco announced that an India health insurer, part of a leading diversified financial services group in India, implemented Majesco Distribution Management (MDM) as the foundation of their distribution transformation. MDM is a standalone, modern solution that enables insurance carriers to manage the entire distribution landscape with comprehensive business capabilities. The announcement was made after market hours yesterday, 21 March 2018.

Axis Bank issued a clarification after market hours yesterday, 21 March 2018 to media reports referring to a bank guarantee issued by the bank to certain telecom companies. Axis Bank said that the bank guarantee has been issued by the bank on behalf of Bharti Airtel. Telecom Disputes Settlement and Appellate Tribunal (TDSAT), vide its order dated 9 January 2018 has required the bank guarantee to be returned. Axis Bank has been informed that the TDSAT order is operative. The bank is seeking clarification from TDSAT on the matter, and will comply with all directions.

Axis Bank clarified that the bank has non-fund based exposure of Rs 9222 crore to the telecom sector as of 31 December 2017, of which approximately 97% is to clients rated AA or better. The bank also informed that it has no exposure to Aircel.

Dilip Buildcon has been declared L-1 bidder by the National Highways Authority of India for a new EPC project valued at Rs 677.07 crore in Uttar Pradesh. The announcement was made after market hours yesterday, 21 March 2018.

Shriram Transport Finance Company said that its allotment committee allotted 1,850 non-convertible debentures (NCDs) aggregating to Rs 185 crore on private placement basis. The announcement was made after market hours yesterday, 21 March 2018.

Powered by Capital Market - Live News

MARKETS
TODAY'S MARKET SECTOR
BSE NSE
Currencies
Currency EUR GBP INR USD
Europe (EUR) 1.00 0.86 90.21 1.08
United Kingdom (GBP) 1.17 1.00 105.20 1.26
India (INR) 0.01 0.01 1.00 0.01
United States (USD) 0.92 0.79 83.34 1.00
Market News << ALL News
  29-Mar-2024, (02:29 )  ICRA reaffirms LT ra..
  29-Mar-2024, (02:16 )  GE Shipping inks dea..
  29-Mar-2024, (01:08 )  RVNL emerges as L-1 ..
  29-Mar-2024, (12:33 )  Macrotech Developers..
 Commodities << ALL Commodities
   Attention Investor: Prevent unauthorized transactions in your trading / Demat account : Update your mobile number / e mail ids with your stock broker / deposit." | "No need to issue cheques by investors while subscribing to IPO.Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account." | "KYC is one time exercise while dealing in securities markets- once KYC is done through a SEBI registered intermediary(broker, DP, Mutual Fund etc.) you need not undergo the same process again when you approach another intermediary."
   Disclaimer   |   BSE Disclosure  |  Privacy Policy   |   Investor Protection   |    Inactive Account   |  Vernacular Language: NSE | BSE   |   Feedback   |    PMLA Policy   |   Risk Management Policy   |   Insider Trading   |   Investor Grivenances   |   Investor Complaints   |   Investor Charter   |   Rules And Regulations   |   Broker Norms   |   Terms of Use    Policies & Procedures   |   Risk Disclosure   |   Do & Don’ts   |   Rights & Obligations
  
SEBI Registration No : INZ000267132   |   BSE Clearing No : 333   
   Copyright © 2011 All rights reserved by Jaysukhlal Jagjivan Stock Broking Pvt.Ltd Designed, Developed & Powered By CMOTS INFOTECH (ISO 9001:2015 certified)